Insight

Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

Photo taken from Nature Communications

May 11, 2024, 12:13

Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter:

“Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.

Multiple EGFR extracellular domain variants not associated with approved targeted therapies were sensitive to afatinib and dacomitinib in vitro
Two patients with glioblastoma with somatic EGFR G598V dimerization domain mutations showed responses to dacomitinib”

Read the article.
Source: Biagio Ricciuti/X
OncoDaily

Afatinib Biagio Ricciuti cancer cancer treatment Dacomitinib EGFR Mutations Extracellular Domain Variants glioblastoma Mutation Scanning OncoDaily Oncology oncology research Research Somatic Mutations targeted therapies TKI Sensitivities

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage